EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020).

Nazeer Mustafa iD, Javed Iqbal, Amama Arshad, Aisha Mubeen

Vascular Biology · 17.11.2026

DOI: 10.1530/vb-25-0005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vascular Biology, online erschienen am 17.11.2026. Verfasst von Nazeer Mustafa und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dow Medical College, Dow University of Health Sciences , Karachi, Pakistan. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lipoprotein metabolism disorders (LMDs) contribute to residual cardiovascular risk following acute myocardial infarction (AMI), yet population-level mortality trends remain poorly defined.

Objective

To evaluate AMI-related mortality trends among U.S. adults with LMDs from 1999–2020.

Methods

A retrospective analysis of CDC WONDER data identified decedents aged ≥25 years with LMDs (ICD-10: E78) contributing to AMI (I21) as underlying cause. Age-adjusted mortality rates (AAMR) per 100,000 were analyzed using joinpoint regression, stratified by demographics.

Results

Among 95,222 deaths, overall AAMR rose from 3.27 (1999) to 4.91 (2020). Three phases emerged: increase (1999–2004; APC: 6.19), stability (2004–2018; APC: -0.39), and resurgence (2018–2020; APC: 6.82). Men had higher AAMR than women (2.88 vs. 1.31). Non-Hispanic Whites (2.1) and Blacks (2.04) showed highest rates; Asians/Pacific Islanders lowest (1.39). Older adults (65–85+ years) bore greatest burden (AAMR: 9.69). Geographically, Midwest (2.33) and West (2.22) exceeded South (1.88) and Northeast (1.77). Non-metropolitan areas had markedly higher AAMR than metropolitan areas (9.08 vs. 2.37). Most deaths occurred in medical facilities (54.65%) versus home (36.71%).

Conclusion

AMI-related mortality among U.S. adults with LMDs increased over two decades, with a concerning resurgence from 2018–2020 coinciding with the COVID-19 pandemic. Persistent disparities by sex, race, age, geography, and urbanization highlight urgent needs for targeted lipid management and equitable healthcare access to reduce cardiovascular mortality in this high-risk population.

Schlagwörter

Stichwörter der Autor:innen

Acute myocardial infarctionage-adjusted mortality ratescardiovascular diseasegender disparitiesgeographic disparitieshealth disparitieslipid-lowering therapieslipoprotein metabolism disorderspublic health interventionsracial disparities

Autor:innen und Institutionen

  • Dow Medical College, Dow University of Health Sciences , Karachi, Pakistan.
  • IPM&R, Dow University of Health Sciences , Karachi, Pakistan.
  • BS Medical Technology Jinnah Sindh Medical University , Karachi, Pakistan.

ORCID-Profile: Nazeer Mustafa

Zitieren

APA

Mustafa, N., Iqbal, J., Arshad, A., & Mubeen, A. (2026). Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020). Vascular Biology. https://doi.org/10.1530/vb-25-0005

Vancouver

Mustafa N, Iqbal J, Arshad A, Mubeen A. Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020). Vascular Biology. 2026. doi:10.1530/vb-25-0005

BibTeX
@article{Mustafa2026,
  author = {Mustafa, Nazeer and Iqbal, Javed and Arshad, Amama and Mubeen, Aisha},
  title = {Temporal Trends and Disparities in Acute Myocardial Infarction Mortality Among Patients with Lipoprotein Metabolism Disorders: A Nationwide CDC-WONDER Analysis (1999–2020)},
  journal = {Vascular Biology},
  year = {2026},
  doi = {10.1530/vb-25-0005}
}
Kostenlos starten →